Bristol Myers Squibb to Participate in Barclays Virtual Global Healthcare Conference
Get Alerts BMY Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 4.5%
Revenue Growth %: +3.2%
Join SI Premium – FREE
NEW YORK--(BUSINESS WIRE)-- Bristol Myers Squibb (NYSE: BMY) today announced that the company will take part in a fireside chat at Barclays’ Virtual Global Healthcare Conference, which will be webcast on Tuesday, March 9, 2021. David Elkins, Executive Vice President, Chief Financial Officer will answer questions about the company at 3 p.m. ET.
Investors and the general public are invited to listen to a live webcast of the session at http://investor.bms.com. Material related to the company’s presentation will be available at the same website at the start of the live webcast. An archived edition of the session will be available later that day.
About Bristol Myers Squibb
Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube, Facebook, and Instagram.
CorporateFinancial-News
View source version on businesswire.com: https://www.businesswire.com/news/home/20210302005092/en/
Bristol Myers Squibb
Media:
[email protected]
Investor Relations:
Tim Power, 609-252-7509, [email protected]
Nina Goworek, 908-673-9711, [email protected]
Source: Bristol Myers Squibb
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tradeweb Reports August 2026 Total Trading Volume of $61.2 Trillion and Average Daily Volume of $2.8 Trillion
- Everblog Simplifies Family Life with New AI-Powered FridgeCal(TM) 2
- Euro Sun Mining Announces Non‑Binding MoU for US$400 Million Senior Debt Facility and Term Sheet for US$3 Million Strategic Equity Investment
Create E-mail Alert Related Categories
Business Wire, Press ReleasesRelated Entities
Barclays, TwitterSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share